home / stock / srne / srne news


SRNE News and Press, Sorrento Therapeutics Inc. From 07/29/22

Stock Information

Company Name: Sorrento Therapeutics Inc.
Stock Symbol: SRNE
Market: NASDAQ
Website: sorrentotherapeutics.com

Menu

SRNE SRNE Quote SRNE Short SRNE News SRNE Articles SRNE Message Board
Get SRNE Alerts

News, Short Squeeze, Breakout and More Instantly...

SRNE - 10 Stocks to Sell Before They Die

InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Profit & Protection newsletter dated July 28, 2022. To make sure you don’t miss any of Tom’s picks,  subscribe to his mailing list here . Sourc...

SRNE - Sorrento rises as FDA clears Phase 1 trial for COVID-19 therapeutic

San Diego, California-based biotech Sorrento Therapeutics ( NASDAQ: SRNE ) traded higher on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) greenlighted an early-stage clinical trial for its oral COVID-19 therapy STI-1558. The FDA has s...

SRNE - Sorrento Therapeutics Announces the FDA IND Clearance of STI-1558, An Oral M(pro) and Cathepsin L Inhibitor to Treat COVID-19

STI-1558, an oral SARS-CoV-2 main protease inhibitor which can block viral replication, is specifically designed as a standalone treatment of COVID-19. Studies to date indicate that STI-1558 does not require the co-administration of ritonavir as a booster for CYP3A4 inhibition. ST...

SRNE - Sorrento Therapeutics: The Enigma

Sorrento's outsized ambitions are not playing well for shareholders. Sorrento has assembled a significant group of COVID-19 assets that could perk up its value as the pandemic smolders ever hotter. Sorrento's performance has not lived up to its potential. Sorrento ( SR...

SRNE - Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today

The back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading session in the volatile healthcare sector is a case in point. For example, shares of the clinical-stage biotech Ocugen (NASDAQ: OCGN) were down by a hefty 9.5% and Sorrento Therape...

SRNE - Sorrento Therapeutics subsidiary Scilex to acquire Ancora Medical

Scilex Holding Co., a subsidiary of  Sorrento Therapeutics ( NASDAQ: SRNE ), is acquiring privately held medtech Ancora Medical . Ancora's key asset is its Nerve Block Catheter Set for surgical pain management during the pre-operative, perioperative and post-opera...

SRNE - Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.

Ancora Medical Inc. (“Ancora”) is a privately held medical technology company with an FDA approved product in February 2020, the Nerve Block Catheter Set which is indicated for surgical pain management during the pre-operative, perioperative and post-operative periods associ...

SRNE - Hot Penny Stocks to Buy This Week? 3 to Watch Right Now 

3 Hot Penny Stocks to Watch During Trading This Week With another dismal start to a week for penny stocks and blue chips, there is a lot for investors to know right now. Although trading penny stocks has not been easy lately, there have been some opportunities for investors to profi...

SRNE - Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors

PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial biopharmaceutical company focused on developing...

SRNE - Best Penny Stocks To Watch? 4 For Your Independence Day List

Penny stocks continue lighting up the boards as retail traders take a breather from investing and focus on day trading. Whether it’s the latest short squeeze stock or meme stocks to watch, daily trends are plentiful when it comes to capitalizing on short-term moves in the stock marke...

Previous 10 Next 10